Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medivant Healthcare is a U.S.-based pharmaceutical manufacturing company focused on sterile injectable products for hospitals, clinics, surgery centers, and physician offices. The company operates under Tailstorm Health and markets itself as a domestic producer of generic injectable drugs intended to address supply shortages in critical care and other hospital-use categories. Its commercial offerings center on single-dose liquid injectable vials, multi-dose formats, prefilled syringes, and repackaged ophthalmic bevacizumab syringes. Medivant emphasizes automated cGMP manufacturing, in-house water-for-injection capability, terminal sterilization, and rapid scalable production from Arizona facilities. The business appears to be a commercial-stage specialty pharma/manufacturer rather than a discovery biotech company, with activity concentrated in manufacturing, shortage mitigation, and hospital supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medivant Healthcare.